Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06926036 · ClinicalTrials.gov registry record · NA
Micromanaging Human Sleep Physiology to Treat Sleep Apnea and Other Disorders
A NA study of Sleep Apnea Obstructive (OSA), sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06926036 is a NA study of Sleep Apnea Obstructive (OSA) that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06926036, a NA study of Sleep Apnea Obstructive (OSA), is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine whether a combination of breathing training during wake and targeted reactivation of the training during sleep can induce breathing changes during sleep and subsequent cognitive benefits during wake. Participants with obstructive sleep apnea (who have not yet been treated for sleep apnea) will be recruited. Participants will engage in breath training for one week in their own homes and to record their sleep at home using commercially available mobile devices and subsequently have their sleep monitored for one night of polysomnography recordings plus targeted reactivation in a laboratory setting.
Conditions Studied
Interventions
- BEHAVIORAL Wake training + TMR
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-04-03 |
| Est. Completion | 2027-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06926036
The ClinicalTrials.gov registry entry for NCT06926036 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sleep Apnea Obstructive (OSA) appearing as the primary indexed condition, and to 1 intervention - of which Wake training + TMR is the first listed.
NCT06926036 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06926036 about?
NCT06926036 is a clinical study titled "Micromanaging Human Sleep Physiology to Treat Sleep Apnea and Other Disorders". This study will examine whether a combination of breathing training during wake and targeted reactivation of the training during sleep can induce breathing changes during sleep and subsequent cognitive benefits during wake. Participants with obstructive sleep apnea (who have not yet been treated fo...
What is the current status of trial NCT06926036?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-04-03. Estimated completion is 2027-04.
What conditions does trial NCT06926036 study?
This clinical trial studies the following conditions: Sleep Apnea Obstructive (OSA).
What interventions are being tested in trial NCT06926036?
The interventions under investigation include: Wake training + TMR (BEHAVIORAL).
Who is sponsoring clinical trial NCT06926036?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06926036 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.